Jean-Paul Pierre Potier

Title: Innovations of Jean-Paul Pierre Potier

Introduction

Jean-Paul Pierre Potier is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that promote the activity of gamma-aminobutyric acid. His work has led to the filing of multiple patents, showcasing his innovative approach to treating nervous disorders.

Latest Patents

Jean-Paul Pierre Potier holds 2 patents. His latest patents include "Angiogenic agents and their uses," which relates to the use of specific compounds for treating nervous disorders. The invention involves a compound of formula I, which includes N substituted 3-amino-2,2-di-c-alkyl-1,4-butyrolactones and 1,4-thiobutyrolactones. This compound is designed to act as a promoter of gamma-aminobutyric acid activity, providing a potential therapeutic avenue for various nervous disorders. Additionally, he has developed methods for preparing these compounds and pharmaceutical compositions containing them.

Career Highlights

Throughout his career, Jean-Paul Pierre Potier has worked with esteemed organizations, including the Centre National de la Recherche Scientifique. His research and innovations have contributed to advancements in medical science, particularly in the area of neurology.

Collaborations

Jean-Paul Pierre Potier has collaborated with notable individuals in his field, including Joanna Bakala and Françoise Lawrence. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

Jean-Paul Pierre Potier's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in treating nervous disorders.